Search

Search Constraints

You searched for: Author/Creator Pisano, Carmela

Search Results

1. 2022-RA-1623-ESGO Effect of bevacizumab and complete cytoreductive surgery in advanced low grade serous ovarian cancer: a secondary analysis of MITO 22. (20th October 2022)

2. A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters. Issue 9 (October 2015)

3. A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: a multicentric Italian experience. Issue 9 (October 2015)

4. Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy. Issue 1 (January 2021)

5. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study. Issue 6 (30th April 2021)

6. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO‐16A/MaNGO‐OV2A study. Issue 6 (June 2021)

7. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2023)

8. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021)

9. Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer. (14th March 2013)

10. Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy. (November 2020)